Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the incidence and describe the changing epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection in Canadian hospitals from 1995-2007. SETTING: Forty-eight hospitals participating in the Canadian Nosocomial Infection Surveillance Program. DESIGN: Prospective, laboratory-based surveillance for incident cases of MRSA colonization or infection among hospitalized patients. METHODS: Clinical and epidemiologic data were obtained by review of hospital records. Standard criteria were used to determine whether MRSA colonization or infection was present and whether the MRSA strain was healthcare associated or community associated. A representative subset of isolates was characterized by use of pulsed-field gel electrophoresis and staphylococcal cassette chromosome (SCC) mec typing. RESULTS: From 1995 to 2007, a total of 37,169 hospitalized patients were newly identified as either infected or colonized with MRSA, and the overall incidence of both MRSA colonization and MRSA infection increased from 0.65 to 11.04 cases per 10,000 patient-days (P < .001). Of these 37,169 patients, 11,828 (32%) had an MRSA infection, and infection rate increased from 0.36 to 3.43 cases per 10,000 patient-days. The proportion of community-associated MRSA strains increased from 6% to 23% (P < .001). The most common genotype (47% of isolates) was CMRSA-2 (USA100/800); in 2007, CMRSA-10 (USA300) was the second most common strain (27% of isolates), associated with SCCmec type IV. Patients with CMRSA-10 were predominantly from western Canada and were more likely to be children (odds ratio [OR], 10.0 [95% confidence interval {CI}, 7.4-13.4]) and to have infection (OR, 2.3 [95% CI, 1.9-2.7]), especially skin and/or soft tissue infection (OR, 5.9 [95% CI, 5.0-6.9]). CONCLUSIONS: The overall incidence of both MRSA colonization and MRSA infection increased 17-fold in Canadian hospitals from 1995 to 2007. There has also been a dramatic increase in cases of community-associated MRSA infection due to the CMRSA-10 (USA300) clone. Continued surveillance is needed to monitor the ongoing evolution of MRSA colonization or infection in Canada and globally.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This ST belongs to clonal complex 5 (CC5), the leading cause of HA-MRSA infection in Canada [30], as well as CA-MRSA colonization in Canada and the United States [30], [31].”
From Carriage of Methicillin-Resistant Staphylococcus aureus by Wild Urban Norway Rats (Rattus norvegicus) (2014) · cites this paper as [30]
Citations
Cites
Horan, T. C., Andrus, M., & Dudeck, M. A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.03.002 · Cited by 6,626 · cited 2×
“4,266 1,136 (27) 2,051 (48) 437 (10) 72 (2) 32(1) 538 (13)”
Canadian Institute for Health Information.
Lalonde, A. (1994) · PubMed · Cited by 4,739
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 4×
“14,234 (38) 12,379 (33) 3,509 (9) 6,939 (19)”
InfluentialCosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964 · cited 3×
“229 (14) 409 (25) 396 (24) 425 (26) 160 (10) 9(1) (%) of patients”
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493 · cited 7×
“1,917 (45) 690 (16) 582 (14) 1,096 (26)”
InfluentialMcDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399 · cited 3×
“14,234 (38) 12,379 (33) 3,509 (9) 6,939 (19)”
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343 · cited 2×
“920 (12) 1,269 (16) 2,899 (37) 1,443 (18) 834 (11) 451 (6) P”
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
Klein, E., Smith, D. L., & Laxminarayan, R. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1312.070629 · Cited by 862 · cited 3×
“4,328 (39) 2,970 (27) 1,587 (14) 2,190 (20)”
Epidemiology of Methicillin‐Resistant Staphylococcus aureus
Boucher, H. W., & Corey, G. R. (2008) · Clinical Infectious Diseases · doi:10.1086/533590 · Cited by 805 · cited 2×
“4,266 1,136 (27) 2,051 (48) 437 (10) 72 (2) 32(1) 538 (13)”
Seybold, U., Kourbatova, E. V., Johnson, J. G., Halvosa, S. J., Wang, Y. F., King, M. D., Ray, S. M., & Blumberg, H. M. (2006) · Clinical Infectious Diseases · doi:10.1086/499815 · Cited by 695
Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002
Tiemersma, E. W., Bronzwaer, S. L. A. M., Lyytikäinen, O., Degener, J. E., Schrijnemakers, P., Bruinsma, N., Monen, J., Witte, W., Grundmann, H., & Participants, E. A. R. S. S. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1009.040069 · Cited by 528
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Deresinski, S. (2005) · Clinical Infectious Diseases · doi:10.1086/427701 · Cited by 466 · cited 6×
“2,607 1,109 (43) 373 (14) 622 (24) 18(1) 1 (0.”
InfluentialThe Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., & Moiduddin, A. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990102 · Cited by 445 · cited 1×
“2,375 (20) 4,237 (36) 2,677 (23) 1,353 (11) 1,637 (14) 605 (5)”
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., Chambers, H. F., Lu, Y., & Otto, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900743106 · Cited by 394 · cited 2×
“488 (14) 697 (20) 942 (28) 809 (24) 359 (10) 145 (4) 2004-2007”
Popovich, K. J., Weinstein, R. A., & Hota, B. (2008) · Clinical Infectious Diseases · doi:10.1086/528716 · Cited by 378 · cited 1×
“14,234 (38) 12,379 (33) 3,509 (9) 6,939 (19)”
Mulvey, M. R., Chui, L., Ismail, J., Louie, L., Murphy, C., Chang, N., Alfa, M., & the Canadian Committee for the Standardization of Molecular Methods (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3481-3485.2001 · Cited by 254 · cited 2×
“1,917 (45) 690 (16) 582 (14) 1,096 (26)”
Self-citationLiu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205 · cited 1×
“5,312 (17) 26,377 (83) 11,828 (32) 25,003 (68)”
What Is Community‐Associated Methicillin‐Resistant Staphylococcus aureus?
David, M. Z., Glikman, D., Crawford, S. E., Peng, J., King, K. J., Hostetler, M. A., Boyle‐Vavra, S., & Daum, R. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/533502 · Cited by 203
Ko, K. S., Lee, J.-Y., Suh, J. Y., Oh, W. S., Peck, K. R., Lee, N. Y., & Song, J.-H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.421-426.2005 · Cited by 202 · cited 4×
“229 (14) 409 (25) 396 (24) 425 (26) 160 (10) 9(1) (%) of patients”
InfluentialGilbert, M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051565 · Cited by 187 · cited 2×
“4,328 (39) 2,970 (27) 1,587 (14) 2,190 (20)”
Evaluation of Three Rapid Methods for Detection of Methicillin Resistance in Staphylococcus aureus
Louie, L., Matsumura, S., Choi, E., Louie, M., & Simor, A. E. (2000) · Journal of Clinical Microbiology · doi:10.1128/.38.6.2170-2173.2000 · Cited by 175 · cited 1×
“637 4(1) 434 (68) 71 (11) 96 (15) 32(5) 2004-2007”
Self-citationJarvis, W. R., Schlosser, J., Chinn, R., Tweeten, S., & Jackson, M. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.009 · Cited by 144
Simor, A. E., Ofner-Agostini, M., Bryce, E., Green, K., McGeer, A., Mulvey, M. R., & Paton, S. (2001) · Europe PMC (PubMed Central) · Cited by 136
Self-citationCommunity-associated Methicillin-resistant Staphylococcus aureus, Canada
Mulvey, M. R., MacDougall, L., Cholin, B., Horsman, G., Fidyk, M., Woods, S., & the Saskatchewan CA-MRSA Study Group (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.041146 · Cited by 134 · cited 2×
“1,917 (45) 690 (16) 582 (14) 1,096 (26)”
Self-citationOtter, J. A., & French, G. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70636-3 · Cited by 120
Aires-de-Sousa, M., Miragaia, M., Santos‐Sanches, I., Ávila, S., Adamsson, I., Casagrande, S. T., Brandileone, M. C. C., Palacio, R., Dell'Acqua, L., Hortal, M., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2197-2205.2001 · Cited by 103
Comparative Genomics of Canadian Epidemic Lineages of Methicillin-Resistant Staphylococcus aureus
Christianson, S., Golding, G. R., Campbell, J., & Mulvey, M. R. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02500-06 · Cited by 95
Self-citationSimor, A. E., Ofner-Agostini, M., Bryce, E., McGeer, A., Paton, S., & Mulvey, M. R. (2002) · The Journal of Infectious Diseases · doi:10.1086/342292 · Cited by 90 · cited 2×
“920 (12) 1,269 (16) 2,899 (37) 1,443 (18) 834 (11) 451 (6) P”
Self-citationPatel, M., Kumar, R. A., Stamm, A. M., Hoesley, C. J., Moser, S. A., & Waites, K. B. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00902-07 · Cited by 60
Ofner-Agostini, M., Varia, M., Johnston, L., Green, K., Simor, A. E., Amihod, B., Bryce, E., Henderson, E., Stegenga, J., Bergeron, F., et al. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.12.003 · Cited by 26 · cited 1×
“4,252 (21) 15,656 (79) 7,255 (34) 14,399 (66)”
Self-citationCommunity‐Based Cluster of Methicillin‐Resistant Staphylococcus Aureus in Manitoba
Kurbis, C., & Wylie, J. (2001) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2001/136953 · Cited by 22
Dalloo, A., Sobol, I., Palacios, C., Mulvey, M., Gravel, D., & Panaro, L. (2008) · PubMed · Cited by 22
Self-citation
Cited by
Nimmo, G. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03822.x · Cited by 201
Thurlow, L. R., Joshi, G. S., & Richardson, A. R. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00937.x · Cited by 166
Chua, K., Laurent, F., Coombs, G., Grayson, M. L., & Howden, B. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq067 · Cited by 159
“The situation in Canada is similar to that in the United States, with USA300 becoming increasingly common [31].”
BackgroundMupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus
Seah, C., Alexander, D. C., Louie, L., Simor, A. E., Low, D. E., Longtin, J., & Melano, R. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05325-11 · Cited by 166
“The three MRSA strains (designated MUP87, MUP88, and MUP91) included in this study were recovered during surveillance conducted by the Canadian Nosocomial Infection Surveillance Program in 2004 (19, 20).”
BackgroundSelf-citationCrago, B., Ferrato, C., Drews, S. J., Svenson, L. W., Tyrrell, G., & Louie, M. (2012) · Food Microbiology · doi:10.1016/j.fm.2012.04.012 · Cited by 128
Metadata
- Authors
- Simor, A. E., Gilbert, N. L., Gravel, D., Mulvey, M. R., Bryce, E., Loeb, M., Matlow, A., McGeer, A., Louie, L., Campbell, J., & Program, C. N. I. S.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Hamilton Health Sciences (CA)
- Vancouver General Hospital (CA)
- Public Health Agency of Canada (CA)
- Mount Sinai Hospital (CA)
- Corresponding author
- Simor, Andrew E.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2010-04
- Volume
- 31
- Issue
- 4
- Pages
- 348-356
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2110116001
- Cited by
- 87
- References
- 35
- Citations by year
- 2026: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 10
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Infection Control and Hospital Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Public Health Agency
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- methicillin-resistant Staphylococcus aureus, MRSA colonization, MRSA infection, nosocomial infections, community-acquired MRSA, healthcare-associated MRSA, epidemiology, incidence trends, SCCmec typing, USA300, USA100, pulsed-field gel electrophoresis, skin and soft tissue infections, Canadian hospitals, Canada, children, antimicrobial resistance
- MeSH terms
- Canada, Cross Infection, Hospitals, Hospitals, Pediatric, Hospitals, Teaching, Humans, Population Surveillance, Staphylococcal Infections, Incidence, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.